© 2004 European Society of Cardiology
NT-proBNP: a marker for successful myocardial reperfusion in AMI patients treated with primary percutaneous coronary intervention
a Isala Klinieken, location De Weezenlanden, Department of Cardiology Groot Wezenland 20, 8011 JW Zwolle, The Netherlands
b Isala Klinieken, location De Weezenlanden, Department of Clinical Chemistry Groot Wezenland 20, 8011 JW Zwolle, The Netherlands
* Corresponding author. Tel.: +31-38-4242374; fax: +31-38-4243222. E-mail address: v.derks@diagram-zwolle.nl
Key Words: NT-proBNP Acute myocardial infarction Percutaneous coronary intervention
Received May 7, 2003; Revised October 1, 2003; Accepted November 13, 2003
| The first 10% of the full text of this article appears below. |
| 1. Background |
|---|
The cardiac natriuretic peptide system is activated in left ventricular (LV) dysfunction and has been evaluated in patients after acute myocardial infarction (AMI) [1–3].
Higher levels of BNP and NT-proBNP in the first few days after AMI is a powerful predictor of LV dysfunction, prognosis in heart failure and death [4–8].
In patients with AMI, early restoration of antegrade flow in the infarct-related artery reduces infarct size and LV dysfunction, improving both short- and long-term outcome [9,10].
Accordingly, BNP kinetics could reflect the success
| 2. Aims |
|---|
| 3. Methods |
|---|
| 4. Results |
|---|
| 5. Conclusion |
|---|